REMUS
Start SIP
Invest Now
Start SIP in REMUS
Performance
- Low
- ₹700
- High
- ₹725
- 52 Week Low
- ₹611
- 52 Week High
- ₹1,210
- Open Price₹723
- Previous Close₹737
- Volume2,900
- 50 DMA₹730.15
- 100 DMA₹766.59
- 200 DMA₹840.05
Investment Returns
- Over 1 Month -0.04%
- Over 3 Month + 2.94%
- Over 6 Month -19.81%
- Over 1 Year -39.16%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.6
- PEG Ratio
- -
- Market Cap Cr
- 830
- P/B Ratio
- 2.7
- Average True Range
- 43.23
- EPS
- 24.53
- Dividend Yield
- 0.1
- MACD Signal
- 6.18
- RSI
- 46.36
- MFI
- 66.4
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹704.55
-32.45
(-4.4%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹728.75
- 50 Day
- ₹730.15
- 100 Day
- ₹766.59
- 200 Day
- ₹840.05
Resistance and Support
709.83
- R3 744.62
- R2 734.78
- R1 719.67
- S1 694.72
- S2 684.88
- S3 669.77
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results & Interim Dividend | |
| 2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-05-16 | Audited Results | |
| 2024-04-23 | Bonus issue & Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹704 As on 12 January, 2026 | 01:41
The Market Cap of Remus Pharmaceuticals is ₹830.2 Cr As on 12 January, 2026 | 01:41
The P/E ratio of Remus Pharmaceuticals is 28.6 As on 12 January, 2026 | 01:41
The PB ratio of Remus Pharmaceuticals is 2.7 As on 12 January, 2026 | 01:41
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.